HLA-A29 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(MHC Class I, A cell surface antigen) | ||||||||||||||||
About | ||||||||||||||||
Protein | transmembrane receptor/ligand | |||||||||||||||
Structure | αβ heterodimer | |||||||||||||||
Subunits | HLA-A*29--, β2-microglobulin | |||||||||||||||
Older names | A19 | |||||||||||||||
Subtypes | ||||||||||||||||
| ||||||||||||||||
Alleles link-out to IMGT/HLA database at EBI |
HLA-A29 (A29) is a human leukocyte antigen serotype within HLA-A serotype group. The serotype is determined by the antibody recognition of α29 subset of HLA-A α-chains. For A29, the alpha "A" chain are encoded by the HLA-A*29 allele group and the β-chain are encoded by B2M locus.[1] This group currently is dominated by A*2902. A29 and A*29 are almost synonymous in meaning. A29 is a split antigen of the broad antigen serotype A19. A29 is a sister serotype of A30, A31, A32, A33, and A74.
A29 is more common in Western Africa and Southwestern Europe.
A*29 | A29 | Sample |
allele | % | size (N) |
*2901 | 96 | 119 |
*2902 | 99 | 1148 |